| Drug Type Fc fusion protein | 
| Synonyms AMPE4L, GLP1-Fc-Leptin | 
| Target | 
| Action agonists | 
| Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists), LEPR agonists(Leptin receptor agonists) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Diabetes Mellitus | Discovery | United States  | - | |
| Obesity | Discovery | United States  | - | 






